3,405
Participants
Start Date
February 28, 2010
Primary Completion Date
July 31, 2010
Study Completion Date
October 31, 2010
Arepanrix®
Injected according to the prescribing information in the locally approved label by the authorities.
Lead Sponsor
GlaxoSmithKline
INDUSTRY